Esperion Therapeutics develops and sells medicines for patients with high cholesterol. Their main products are NEXLETOL and NEXLIZET tablets for treating cardiovascular disease and hypercholesterolemia. They have partnerships with Daiichi Sankyo Europe and Serometrix for licensing and collaboration. The company was founded in 2008 and is based in Ann Arbor, Michigan.